Therapy for mothers with PTSD and their young children
Can Clinician Assisted Videofeedback Exposure Approach Therapy (CAVEAT) Help Post-traumatically Stressed Mothers Change Their Mind About Their Toddlers?
NA · University of Lausanne Hospitals · NCT05927324
This study is testing a new therapy program for mothers with PTSD to see if it helps them connect better with their young children.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 24 (estimated) |
| Ages | 18 Years to 50 Years |
| Sex | Female |
| Sponsor | University of Lausanne Hospitals (other) |
| Locations | 1 site (Lausanne, Canton of Vaud) |
| Trial ID | NCT05927324 on ClinicalTrials.gov |
What this trial studies
This study evaluates the feasibility of a 16-session psychotherapy program called Clinician-Assisted Videofeedback Exposure-Approach Therapy (CAVEAT) designed for mothers who have experienced interpersonal violence and are suffering from post-traumatic stress disorder (PTSD). The therapy integrates evidence-based techniques such as Modified Interaction Guidance and Prolonged Exposure Therapy to help mothers improve their emotional regulation and sensitivity during interactions with their infants and young children. The trial will involve a small group of 10 to 12 participants at a Swiss public hospital, focusing on the therapeutic impact on both mothers and their children aged 1 to 5 years. The study aims to assess the practicality of this approach in a clinical setting.
Who should consider this trial
Good fit: Ideal candidates are biological mothers of infants and young children aged 12 to 54 months who have experienced interpersonal violence.
Not a fit: Patients who are actively psychotic, substance-abusing, or have physical or mental handicaps that hinder participation will not benefit from this study.
Why it matters
Potential benefit: If successful, this therapy could significantly improve the mental health and parenting skills of mothers with PTSD, leading to better outcomes for both mothers and their children.
How similar studies have performed: While this specific approach is novel, it builds on established evidence-based techniques that have shown success in related therapeutic contexts.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Biological mothers of infants and young children ages 12-54 months * Mothers and infants have lived together most of the child's life from the time of birth Exclusion Criteria: * Actively psychotic or substance-abusing mothers; * Mothers and/or children who are physically or mentally handicapped so as to prevent adequate participation in required research tasks
Where this trial is running
Lausanne, Canton of Vaud
- Lausanne University Hospital — Lausanne, Canton of Vaud, Switzerland (RECRUITING)
Study contacts
- Study coordinator: Daniel S Schechter, MD
- Email: daniel.schechter@unige.ch
- Phone: +41213145285
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Post-traumatic Stress Disorder, Interpersonal Violence, PTSD, Women, Infants and Children, Attachment